Fat Loss Stack

Disclaimer

THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

What it is

The Fat Loss Stack combines AOD-9604, a modified fragment of human growth hormone studied for its role in lipolysis without broader GH-axis effects, Tesamorelin, a GHRH analog studied specifically for its effects on visceral fat, and MOTS-c, a mitochondrial-derived peptide studied for metabolic signaling. This is a GH-axis approach to fat-metabolism research, distinct from the incretin-based mechanism behind the Metabolic Duo.

Studied in research for

Research on Tesamorelin has focused on GH/IGF-1-mediated reduction of visceral adipose tissue, AOD-9604 has been studied for lipolytic signaling isolated from GH's growth-promoting effects, and MOTS-c has been examined for its role in metabolic and mitochondrial regulation \u2014 a combination frequently referenced together in GH-axis fat-metabolism research.

Handling & storage

Each compound is supplied as a separate lyophilized vial (AOD-9604 5mg, Tesamorelin 10mg, and MOTS-c 40mg). Store refrigerated or frozen, protected from light, prior to reconstitution. Reconstitute and handle each vial according to its individual protocol.